gentian violet has been researched along with cyclic gmp in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Billiar, TR; Deng, M; Loughran, PA; Scott, MJ; Zhang, L | 1 |
Hu, LF; Li, X; Lu, RF; Ni, B; Sun, JF; Wu, QM; Xue, XF; Yang, WH; Yin, Z; Zhang, YQ; Zhnag, MM; Zhou, DS | 1 |
2 other study(ies) available for gentian violet and cyclic gmp
Article | Year |
---|---|
Shedding of the tumor necrosis factor (TNF) receptor from the surface of hepatocytes during sepsis limits inflammation through cGMP signaling.
Topics: ADAM Proteins; ADAM17 Protein; Analysis of Variance; Animals; Blotting, Western; Caspase 1; Coinfection; Cyclic GMP; Enzyme Activation; Gentian Violet; Hepatocytes; Humans; Lipopolysaccharides; Mice; Mice, Inbred C57BL; Mice, Knockout; Microscopy, Fluorescence; Myeloid Differentiation Factor 88; Nitric Oxide Synthase Type II; Proteolysis; Real-Time Polymerase Chain Reaction; Receptors, Tumor Necrosis Factor; Reverse Transcriptase Polymerase Chain Reaction; Sepsis; Signal Transduction | 2015 |
H-NS Represses Biofilm Formation and c-di-GMP Synthesis in
Topics: Bacterial Proteins; Biofilms; Cyclic GMP; Gene Expression Regulation, Bacterial; Gentian Violet; Histones; Vibrio parahaemolyticus | 2022 |